Search results
IT survey shows strong demand amid AI revolution: BofA By Investing.com
Investing.com· 42 minutes agoIT survey shows strong demand amid AI revolution: BofA
Alaskan youth sue state to block proposed natural gas pipeline project, citing health & climate...
Alaska News Source· 12 hours agoSaying a state policy promoting fossil fuels violates their constitutional rights by putting their...
Mountain Valley Pipeline in-service date delayed again
WDTV· 18 hours agoEarlier this month, the Mountain Valley Pipeline’s projected official in-service date was set for...
Energy Transfer to pay more than $3 billion to expand its Permian pipeline
Market Watch· 24 hours agoEnergy Transfer said the deal will expand its natural gas pipeline and processing network in the...
Columbus McKinnon posts Q4 earnings miss, guides for FY25 sales growth By Investing.com
Investing.com· 2 hours agoColumbus McKinnon posts Q4 earnings miss, guides for FY25 sales growth
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 22 hours agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging ...
OneSoft Report Results of AGSM and Grant of Stock Options
Morningstar· 1 hour agoEDMONTON, AB / ACCESSWIRE / May 29, 2024 / OneSoft Solutions Inc. (TSXV:OSS)(OTCQB:OSSIF) ("OneSoft" or the "Company") announces that the Company's Annual General and Special Meeting ("AGSM" ...
Mountain Valley Pipeline completion delayed again
WSLS Newschannel 10 Roanoke· 5 days agoThe planned in-service date for the Mountain Valley Pipeline is not quite narrowed down after developers delayed the original June 1 date. This week, the...
Who is Daniel Kretinsky, the Czech billionaire trying to buy Royal Mail?
PA Media: Money via Yahoo Finance· 54 minutes agoThey include Eustream, which moves Russian gas via pipelines running through Ukraine, the Czech...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 1 day agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...